| Product Code: ETC11530785 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Companion Diagnostic Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Companion Diagnostic Market - Industry Life Cycle |
3.4 Serbia Companion Diagnostic Market - Porter's Five Forces |
3.5 Serbia Companion Diagnostic Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Serbia Companion Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Serbia Companion Diagnostic Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Serbia Companion Diagnostic Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 Serbia Companion Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Serbia Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Serbia leading to higher demand for companion diagnostics |
4.2.2 Growing investments in healthcare infrastructure and research and development activities in the country |
4.2.3 Rising awareness about personalized medicine and its benefits among healthcare professionals and patients in Serbia |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of companion diagnostics in Serbia |
4.3.2 Limited reimbursement policies for companion diagnostic tests in the country |
4.3.3 Lack of skilled professionals and infrastructure for conducting advanced companion diagnostic tests |
5 Serbia Companion Diagnostic Market Trends |
6 Serbia Companion Diagnostic Market, By Types |
6.1 Serbia Companion Diagnostic Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Companion Diagnostic Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Serbia Companion Diagnostic Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Serbia Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry, 2021 - 2031F |
6.1.5 Serbia Companion Diagnostic Market Revenues & Volume, By Next-Gen Sequencing, 2021 - 2031F |
6.1.6 Serbia Companion Diagnostic Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.2 Serbia Companion Diagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Serbia Companion Diagnostic Market Revenues & Volume, By Drug Response Testing, 2021 - 2031F |
6.2.3 Serbia Companion Diagnostic Market Revenues & Volume, By Biomarker Testing, 2021 - 2031F |
6.2.4 Serbia Companion Diagnostic Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.5 Serbia Companion Diagnostic Market Revenues & Volume, By Disease Identification, 2021 - 2031F |
6.3 Serbia Companion Diagnostic Market, By Disease Area |
6.3.1 Overview and Analysis |
6.3.2 Serbia Companion Diagnostic Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Serbia Companion Diagnostic Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.3.4 Serbia Companion Diagnostic Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.5 Serbia Companion Diagnostic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4 Serbia Companion Diagnostic Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Serbia Companion Diagnostic Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Serbia Companion Diagnostic Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Serbia Companion Diagnostic Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Serbia Companion Diagnostic Market Revenues & Volume, By Urine, 2021 - 2031F |
6.5 Serbia Companion Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Serbia Companion Diagnostic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Serbia Companion Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5.4 Serbia Companion Diagnostic Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Serbia Companion Diagnostic Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
7 Serbia Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Serbia Companion Diagnostic Market Export to Major Countries |
7.2 Serbia Companion Diagnostic Market Imports from Major Countries |
8 Serbia Companion Diagnostic Market Key Performance Indicators |
8.1 Average turnaround time for companion diagnostic test results |
8.2 Number of collaborations between diagnostic companies and healthcare institutions in Serbia |
8.3 Adoption rate of companion diagnostic tests by healthcare providers in the country |
9 Serbia Companion Diagnostic Market - Opportunity Assessment |
9.1 Serbia Companion Diagnostic Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Serbia Companion Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Serbia Companion Diagnostic Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.4 Serbia Companion Diagnostic Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.5 Serbia Companion Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Serbia Companion Diagnostic Market - Competitive Landscape |
10.1 Serbia Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Serbia Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here